1
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Hay ED: The mesenchymal cell, its role in
the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 233:706–720. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hsu DS, Lan HY, Huang CH, Tai SK, Chang
SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY, et al: Regulation
of excision repair cross-complementation group 1 by Snail
contributes to cisplatin resistance in head and neck cancer. Clin
Cancer Res. 16:4561–4571. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chiou SH, Kao CL, Chen YW, Chien CS, Hung
SC, Lo JF, Chen YJ, Ku HH, Hsu MT and Wong TT: Identification of
CD133-positive radioresistant cells in atypical teratoid/rhabdoid
tumor. PLoS One. 3:e20902008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chen YC, Chang CJ, Hsu HS, Chen YW, Tai
LK, Tseng LM, Chiou GY, Chang SC, Kao SY, Chiou SH, et al:
Inhibition of tumorigenicity and enhancement of
radiochemosensitivity in head and neck squamous cell cancer-derived
ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol. 46:158–165.
2010. View Article : Google Scholar
|
7
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yang AD, Fan F, Camp ER, van Buren G, Liu
W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Chen YC, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
La Fleur L, Johansson AC and Roberg K: A
CD44high/EGFRlow subpopulation within head
and neck cancer cell lines shows an epithelial-mesenchymal
transition phenotype and resistance to treatment. PLoS One.
7:e440712012. View Article : Google Scholar
|
13
|
Yoshikawa M, Tsuchihashi K, Ishimoto T,
Yae T, Motohara T, Sugihara E, Onishi N, Masuko T, Yoshizawa K,
Kawashiri S, et al: xCT inhibition depletes CD44v-expressing tumor
cells that are resistant to EGFR-targeted therapy in head and neck
squamous cell carcinoma. Cancer Res. 73:1855–1866. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Burkert J, Otto WR and Wright NA: Side
populations of gastrointestinal cancers are not enriched in stem
cells. J Pathol. 214:564–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Moody SE, Perez D, Pan TC, Sarkisian CJ,
Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and
Chodosh LA: The transcriptional repressor Snail promotes mammary
tumor recurrence. Cancer Cell. 8:197–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Debies MT, Gestl SA, Mathers JL, Mikse OR,
Leonard TL, Moody SE, Chodosh LA, Cardiff RD and Gunther EJ: Tumor
escape in a Wnt1-dependent mouse breast cancer model is enabled by
p19Arf/p53 pathway lesions but not p16Ink4a
loss. J Clin Invest. 118:51–63. 2008. View
Article : Google Scholar
|
18
|
Kudo-Saito C, Shirako H, Takeuchi T and
Kawakami Y: Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer
Cell. 15:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Vincent T, Neve EP, Johnson JR, Kukalev A,
Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL,
et al: A SNAIL1-SMAD3/4 transcriptional repressor complex promotes
TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol.
11:943–950. 2009. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Yokoyama K, Kamata N, Hayashi E, Hoteiya
T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of
E-cadherin and snail expression in oral squamous cell carcinoma
cells in svitro. Oral Oncol. 37:65–71. 2001. View Article : Google Scholar
|
21
|
Peinado H, Ballestar E, Esteller M and
Cano A: Snail mediates E-cadherin repression by the recruitment of
the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell
Biol. 24:306–319. 2004. View Article : Google Scholar :
|
22
|
Masui T, Ota I, Yook JI, Mikami S, Yane K,
Yamanaka T and Hosoi H: Snail-induced epithelial-mesenchymal
transition promotes cancer stem cell-like phenotype in head and
neck cancer cells. Int J Oncol. 44:693–699. 2014.
|
23
|
Hayashi K, Motoyama S, Sugiyama T, Izumi
J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y, Koyota S,
et al: REG Ialpha is a reliable marker of chemoradiosensitivity in
squamous cell esophageal cancer patients. Ann Surg Oncol.
15:1224–1231. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim
NH, Cha SY, Ryu JK, Choi YJ, Kim J, et al: A Wnt-Axin2-GSK3beta
cascade regulates Snail1 activity in breast cancer cells. Nat Cell
Biol. 8:1398–1406. 2006. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Ota I, Li XY, Hu Y and Weiss SJ: Induction
of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration
program in cancer cells by Snail1. Proc Natl Acad Sci USA.
106:20318–20323. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Imai T, Tamai K, Oizumi S, Oyama K,
Yamaguchi K, Sato I, Satoh K, Matsuura K, Saijo S, Sugamura K, et
al: CD271 defines a stem cell-like population in hypopharyngeal
cancer. PLoS One. 8:e620022013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Fukusumi T, Ishii H, Konno M, Yasui T,
Nakahara S, Takenaka Y, Yamamoto Y, Nishikawa S, Kano Y, Ogawa H,
et al: CD10 as a novel marker of therapeutic resistance and cancer
stem cells in head and neck squamous cell carcinoma. Br J Cancer.
111:506–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Brunner M, Thurnher D, Pammer J, Geleff S,
Heiduschka G, Reinisch CM, Petzelbauer P and Erovic BM: Expression
of VEGF-A/C, VEGF-r2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu,
Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol. 21:876–884.
2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhang P, Zhang Y, Mao L, Zhang Z and Chen
W: Side population in oral squamous cell carcinoma possesses tumor
stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS,
Tseng LM, Hung SC, Kao SY, Chang CJ and Chiou SH: Bmi-1 regulates
Snail expression and promotes metastasis ability in head and neck
squamous cancer-derived ALDH1 positive cells. J Oncol. 2011:pii:
609259. 2011. View Article : Google Scholar
|
31
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
32
|
Abelev GI and Lazarevich NL: Control of
differentiation in progression of epithelial tumors. Adv Cancer
Res. 95:61–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Jeter Cr, Badeaux M, Choy G, Chandra D,
Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ and Tang
DG: Functional evidence that the self-renewal gene NANOG regulates
human tumor development. Stem Cells. 27:993–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Jeter CR, Liu B, Liu X, Chen X, Liu C,
Calhoun-Davis T, Repass J, Zaehres H, Shen JJ and Tang DG: NANOG
promotes cancer stem cell characteristics and prostate cancer
resistance to androgen deprivation. Oncogene. 30:3833–3845. 2011.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
36
|
Chen C, Wei Y, Hummel M, Hoffmann TK,
Gross M, Kaufmann AM and Albers AE: Evidence for
epithelial-mesenchymal transition in cancer stem cells of head and
neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Dang H, Ding W, Emerson D and Rountree CB:
Snail1 induces epithelial-to-mesenchymal transition and tumor
initiating stem cell characteristics. BMC Cancer. 11:3962011.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Niwa H: Molecular mechanism to maintain
stem cell renewal of ES cells. Cell Struct Funct. 26:137–148. 2001.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Wang D, Su L, Huang D, Zhang H, Shin DM
and Chen ZG: Downregulation of E-Cadherin enhances proliferation of
head and neck cancer through transcriptional regulation of EGFR.
Mol Cancer. 10:1162011. View Article : Google Scholar : PubMed/NCBI
|
40
|
Emmink BL, Van Houdt WJ, Vries RG,
Hoogwater FJ, Govaert KM, Verheem A, Nijkamp MW, Steller EJ,
Jimenez CR, Clevers H, et al: Differentiated human colorectal
cancer cells protect tumor-initiating cells from irinotecan.
Gastroenterology. 141:269–278. 2011. View Article : Google Scholar : PubMed/NCBI
|